| 8th Dec 2022 7:00 am |
RNS |
Half-year Report |
| 2nd Dec 2022 7:00 am |
RNS |
Notice of Half Year Results |
| 30th Nov 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 30th Nov 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 16th Nov 2022 7:00 am |
RNS |
Study started of new SFX-01 tablet formulation |
| 21st Oct 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 21st Oct 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 12th Oct 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 12th Oct 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 12th Oct 2022 7:00 am |
RNS |
Clinical trial update |
| 10th Oct 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 10th Oct 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 10th Oct 2022 7:00 am |
RNS |
SFX-01 licensing deal for up to $160.5m |
| 29th Sep 2022 7:00 am |
RNS |
Regulatory approval for healthy volunteer study |
| 22nd Jul 2022 7:00 am |
RNS |
Result of AGM |
| 14th Jul 2022 12:43 pm |
RNS |
Investor Presentation |
| 6th Jul 2022 12:25 pm |
RNS |
Notice of AGM |
| 13th Jun 2022 7:00 am |
RNS |
Collaboration with University of Michigan |
| 8th Jun 2022 7:00 am |
RNS |
Full Year Results |
| 7th Jun 2022 7:00 am |
RNS |
Notice of Results |
| 25th May 2022 7:00 am |
RNS |
Collaboration with Università Sapienza di Roma |
| 29th Apr 2022 2:39 pm |
RNS |
Holding(s) in Company |
| 15th Mar 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 15th Mar 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 7th Mar 2022 7:00 am |
RNS |
Manchester Breast Centre collaboration expanded |
| 18th Jan 2022 7:00 am |
RNS |
Option over new sulforaphane analogues |
| 11th Jan 2022 7:00 am |
RNS |
Progress with UK and US regulators for 2022 trials |
| 30th Dec 2021 11:35 am |
RNS |
Holding(s) in Company |
| 8th Dec 2021 2:08 pm |
RNS |
Grant of Options |
| 7th Dec 2021 7:00 am |
RNS |
Half-year Report |
| 23rd Nov 2021 7:00 am |
RNS |
Notice of Results |
| 10th Nov 2021 7:00 am |
RNS |
Publication of data on SFX-01 in glioblastoma |
| 19th Oct 2021 2:39 pm |
RNS |
Holding(s) in Company |
| 20th Sep 2021 7:00 am |
RNS |
Publication of data in glioblastoma cells |
| 2nd Sep 2021 2:32 pm |
RNS |
Holding(s) in Company |
| 2nd Sep 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 2nd Sep 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 2nd Sep 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 2nd Sep 2021 11:01 am |
RNS |
Glioma Orphan Drug designation granted by FDA |
| 2nd Sep 2021 11:00 am |
RNS |
Price Monitoring Extension |
